Related Experiment Video
Updated: Feb 14, 2026

Polymer Microarrays for High Throughput Discovery of Biomaterials
Published on: January 25, 2012
High-Throughput Kinetic Analysis for Target-Directed Covalent Ligand Discovery
Gregory B Craven1,2, Dominic P Affron1, Charlotte E Allen1
1Department of Chemistry, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Quantitative irreversible tethering (qIT) identifies selective covalent ligands for biological targets. This method discovered a novel allosteric Cdk2 inhibitor, advancing drug discovery for cell cycle regulation.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Chemical Biology
Background:
- Cysteine-reactive small molecules serve as crucial chemical probes and therapeutic agents.
- Distinguishing selective covalent ligands from pan-reactive compounds necessitates rigorous kinetic analysis.
- Developing selective inhibitors is vital for targeted therapeutic applications.
Purpose of the Study:
- To introduce quantitative irreversible tethering (qIT) as a method for screening cysteine-reactive small molecules.
- To prospectively apply qIT for the discovery of covalent fragments targeting Cyclin-dependent kinase 2 (Cdk2).
- To validate the identified inhibitors through structural analysis and explore their therapeutic potential.
Main Methods:
- Development and application of quantitative irreversible tethering (qIT) for kinetic selectivity maximization.
- Prospective screening of cysteine-reactive small molecules against the cell cycle regulator Cdk2.
- X-ray crystallography to determine the structures of Cdk2-inhibitor complexes.
Main Results:
- Successful application of qIT to identify covalent fragments targeting Cdk2.
- Structural validation of the identified inhibitors, guiding further optimization efforts.
- Discovery of a Cdk2-selective allosteric (Type IV) kinase inhibitor with a novel mechanism.
Conclusions:
- Quantitative irreversible tethering (qIT) is a powerful technique for discovering selective covalent ligands.
- The identified Cdk2 inhibitor represents a promising lead for therapeutic development due to its novel allosteric mode-of-action.
- This approach holds significant potential for advancing drug discovery in oncology and other therapeutic areas.
More Related Videos
09:34Synthesis of Information-bearing Peptoids and their Sequence-directed Dynamic Covalent Self-assembly
Published on: February 6, 2020
08:18Author Spotlight: Unraveling Vitamin A Transport Mechanisms — Linking Liver Receptors to Vision Health Through RBPR2 and RBP4 Interactions
Published on: October 4, 2024
Related Concept Videos
Covalent Bonds
Covalent Bonds
When two atoms share electrons to complete their valence shells, they create a covalent bond. An atom's electronegativity—the force with which shared electrons are pulled towards an atom—determines how the electrons are shared. Molecules formed with covalent bonds can be either polar or nonpolar. Atoms with similar electronegativities form nonpolar covalent bonds; the electrons are shared equally. Atoms with different electronegativities share electrons unequally,...
Network Covalent Solids
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
Covalent Bonding and Lewis Structures